ION
Dead / Abandoned — Abandoned — after inter partes decision (as of 16 Feb 2023)
What this means for you
This application is over — abandoned 16 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97164085
- Mark type
- Stylized text
- Filed
- 09 Dec 2021
- Published for opposition
- 25 Oct 2022
- Abandoned
- 16 Feb 2023
- Attorney of record
- TODD BRAVERMAN, ESQ.
Goods and services
- Class 044 — Medical, beauty and agricultural services: Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period
Owner
- C2i Genomics, Inc., New York, NY, US
- C2i Genomics, Inc., New York, NY, US
Prosecution history
- 16 Feb 2023 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 16 Feb 2023 — ABANDONMENT - AFTER INTER PARTES DECISION
- 16 Feb 2023 — OPPOSITION TERMINATED NO. 999999
- 16 Feb 2023 — OPPOSITION SUSTAINED NO. 999999
- 17 Nov 2022 — OPPOSITION INSTITUTED NO. 999999
- 17 Nov 2022 — OPPOSITION PAPERS RECEIVED AT TTAB
- 25 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Oct 2022 — PUBLISHED FOR OPPOSITION
- 05 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2022 — ASSIGNED TO EXAMINER
- 14 Dec 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Dec 2021 — NEW APPLICATION ENTERED